Mammography Market Overview

Mammography is a breast imaging technology used as a screening method for the faster detection of signs of breast cancer in women experiencing no symptoms. Mammograms are low dose x-ray images that can also detect and diagnose breast disease in women experiencing symptoms like pain, a lump, skin dimpling, and nipple discharge.

At the same time, this screening method allows doctors to push boundaries with this latest imaging technologies to precisely visualize cancerous cells and study its behavior and growth. All these factors commutatively add up to deliver effective outcomes in the treatment of breast cancer and other disease related to breast.

Therefore, the mammography is considered as a proven method for earlier detection in breast screening programs. As a result, the mammography market is accruing rapidly. Undoubtedly, technological advancements transpired in the medical science and biotechnology are some of the major driving forces that escalate the market on the global platform.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2443

Considering the traction, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global mammography market will register a CAGR over 22% during 2016 – 2022, accruing pervasively by 2022. The market is predominantly driven by the increase in the number of breast cancer patients, spreading awareness about health, and increase in healthcare expenditures.

Additional factors such as increasing population, genetic mutations (abnormal changes), and exposures to harmful radiation

are substantiating the market growth. Simultaneously, increasing healthcare expenditures and increasing government initiatives are supporting the market growth, spreading awareness among people.

On the other hand, factors such as the high cost of the mammography devices and long approval time of clinical trials are obstructing the market growth. Nevertheless, the unmet clinical needs, especially in the developing regions, are expected to support market growth, providing ample scope to the market to evolve further.

Although less deadly, breast cancer is the most frequently diagnosed of all cancers after skin cancer and its prevalence is on the constant rise. Over the past few years, breast cancer deaths have declined dramatically, however, the mortality rate among women from underdeveloped regions is still disproportionally high. Many women from medically underdeveloped regions do not have adequate access to screening mammograms.

Global Mammography Market – Segments

MRFR has segmented the report into three key dynamics for an easy grasp;

By Technology: Digital Mammography, 3D Mammography, C-View 2D, Breast Tomosynthesis Contrast Enhance Mammography, and Analog among others.

By Application: Screening and Diagnostic among others.

By Regions: North America, Europe, Asia Pacific, and the Rest-of-the-World.

Global Mammography Market – Geographical Analysis

The North American region dominates the global mammography market owing to the presence of leading market players and well-developed technologies. The regional market growth is largely supported by the mammography market in the US that is heading with the large patient pool and substantial healthcare expenditures.

Furthermore, the increasing prevalence of breast cancer fuelled by the consequences of the wrong lifestyle fosters the market growth in the region. Also, factors such as well-spread awareness among people towards the benefits of mammography and increasing government support for research and development, support the market growth.

The European region commands the second position in terms of the market share due to the strong government support and funds. The mammography market in this region is rapidly emerging as a lucrative space owing to the increasing number of breast cancer patients and the proliferation of advanced treatment facilities alongside the availability of skilled medical professionals.

The Asia Pacific region accounts for a promising market for the mammography. Factors substantiating the market growth include the increasing prevalence and the spreading awareness among people about breast cancer. The presence of emerging economies with massive populations that create a huge demand for good healthcare. Proliferating markets in India and China contribute to the market growth in the region majorly.

Global Mammography Market – Competitive Landscape

The fiercely competitive, mammography market appears fragmented with the several large and small-scale players forming a competitive landscape. Significant investments are made in the field of R&D to bring novelties in this screening tool and its clinical trials. Through the strategic initiatives such as partnership, acquisition, expansion, product & technology launch, and collaboration, these players try to gain a competitive edge in the market.

Key Players:

Some of the imminent players in the mammography market are Siemens Healthcare GmbH, Toshiba Medical Systems Corporation, FUJIFILM Holdings Corporation, Shimadzu Corporation, General Electric Company, Koninklijke Philips, Hitachi Medical Corporation, Carestream Health, Inc., and Hologic, Inc.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/mammography-market-2443

Industry/ Innovation/Related News:

January 02, 2019 ---- UC Health (US) published its study on new mammogram its doctors conducted. The study reveals that the new mammogram will help save lives. The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) was developed in conjunction with approximately 130 institutions participating in. The ultimate goal of the study was to achieve a health algorithm or (an) imaging strategy for women so that we can better detect breast cancer at earlier stages.

December 14, 2018 – Southwest Medical Center Board (SWMC board – US) approved the purchase of a 3D mammography unit at SWMC in Liberal. The unanimously approved the new 3D unit will replace the current 2D digital mammography system giving access to patients to enhanced breast imaging services closer to home.